Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029
NEW YORK, March 4, 2019 /PRNewswire/ --
North America, Europe, India, Rest of the World (RoW)
The top 10 generic drug producers have 61% share of the total revenue made by these top 50 companies. 22% of the top 50 generic drug producers are in North America. 30% of the top 50 generic drug producers fall under the RoW region. This figure reflects the increasing penetration of generics on a global scale with many pharmaceutical companies realising this industry as a primary source of revenue.
Read the full report: https://www.reportlinker.com/p05089834
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 207-page report you will receive 74 tables and 72 figures– all unavailable elsewhere.
The 207-page report provides clear detailed insight into the top 50 generic drug producers. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• This report ranks the world's top 50 generic drug manufacturers according to their generic drug revenues in 2017.
Our report assesses the leading generic drug manufacturers worldwide. In general a company profile gives you the following information:
• Discussion of activities, technologies and recent financial results
• Assessment of developments – mergers and acquisitions (M&A), new products, outlooks, challenges and plans
• Historical revenue ($) and CAGR (%) of top players
• Forecasting of generic drug revenues to 2029 (for 18 leading companies).
This report discusses the factors that affect the industry:
• M&A activity and related partnerships
• Global and regional strategies – extending business reach
• Competition from companies based in emerging national markets
• Increasing specialisation by leading players, including big pharma companies
• Increasing consolidation of the generics industry
• Advances in production technologies, including difficult-to-make generics and biosimilars – important shifts and opportunities in the industry.
This report analyses the leading generic drug manufacturers in North America, including these companies:
• Abbott
• Akorn
• Alvogen
• Endo
• Impax
• Mallinckrodt
• Mylan
• Pfizer
• Pharmascience
• Valeant
This report analyses the leading generic drug manufacturers in Europe, including these companies:
• Fresenius Kabi
• Gedeon Richter
• Insud Pharma
• Krka
• Novartis (Sandoz)
• Perrigo
• Pharmstandard
• Polpharma
• Sanofi
• Stada Arzneimittel
This report analyses the leading generic drug manufacturers in India, including these companies:
• Sun Pharmaceuticals
• Aurobindo
• Lupin
• Cipla
• Dr Reddy's
• Glenmark
• Torrent Pharma
• Cadila
• Wockhardt
• Ipca
This report analyses the leading generic drug manufacturers in RoW, including these companies:
• Teva
• EMS
• Aspen
• Sawai Pharmaceutical
• Nichi-Iko
• Abdi Ibrahim
• Towa Pharmaceutical
• Eurofarma
• Taro Pharmaceutical
• Hypermarcas
Read the full report: https://www.reportlinker.com/p05089834
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article